| ACRS YTD Return Table | ||||||||||||||||||||||||||||||
ACRS YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare ACRS YTD return (see YTD Return Formula;
YTD Return vs Yield) versus benchmarks: YTD Return on S&P YTD Return on Dow YTD Return on Nasdaq 100 YTD Return on Russell 2000 YTD Return on Gold YTD Return on 10 Year Treasury |
| ACRS Share Performance |
| ACRS YTD Return Chart | |||
| |||
| About Aclaris Therapeutics Inc |
| Aclaris Therapeutics is a biopharmaceutical company focused on immuno-inflammatory diseases. Co.'s pipeline of drug candidates includes: ATI-450 mitogen-activated protein kinase-activated protein kinase 2 Inhibitor Oral for the indication of Rheumatoid Arthritis plus Additional Immuno-inflammatory Indication; and ATI-1777 Janus kinase (JAK)1/JAK3 Inhibitor Soft Topical for the indication of Atopic Dermatitis. ESKATA, Co.'s only U.S. Food and Drug Administration (FDA)-approved product, is a formulation of high-concentration hydrogen peroxide topical solution which is approved by the FDA as an office-based prescription treatment for raised seborrheic keratosis, a non-malignant skin tumor. The ACRS YTD return is shown above.
The YTD Return on the ACRS YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether ACRS YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ACRS YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| ACRS Current Stock Quote |
Get Free SEC filing alerts for ACRS:
ACRS SEC Filing Email Alerts Service 
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Aclaris Therapeutics (ACRS) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
ACRX YTD Return |
Video: Don't Forget Dividends in YTD Return!